10 January 2020

Sheffield joins national trial of new treatment for major trauma patients


Sheffield Teaching Hospitals NHS Foundation Trust has become one of 11 major trauma centres across the country to recruit patients to a national trial researching the best way to stop bleeding in patients with severe injuries.

 

The UK-REBOA trial is looking at whether inserting a balloon into the aorta (the main artery that carries blood away from the heart) of a patient with life threatening bleeding from their abdomen or pelvis can improve their outcome.

Bleeding is the most common cause of preventable death after severe injury, and research has shown that early treatment for it can save lives. Stopping the bleeding usually requires an operation.

REBOA, which stands for Resuscitative Endovascular Balloon Occlusion of the Aorta, is a new treatment that involves passing a small inflatable balloon into the aorta to stop the bleeding until the patient can be taken to an operating theatre, when the balloon is then removed.

The trial aims to establish the clinical and cost-effectiveness of REBOA, in addition to the standard treatment. It is funded by the National Institute for Health Research (NIHR).

Dr Stuart Reid, Consultant in Emergency Medicine and Major Trauma, is the Principal Investigator for the study at Sheffield Teaching Hospitals.

He said: “It is very exciting for us to be able to contribute to cutting edge major trauma research in the UK. It is the result to close collaboration between a number of specialties within the Sheffield Adult Major Trauma Centre and the research teams.”

The REBOA study is led and coordinated by Mr Jan Jansen and Professor Marion Campbell of the University of Aberdeen.

 

Photo: (Left to right) Dr Steve Rowe, Consultant in Anaesthesia and Major Trauma;
Neil Strawbridge, Trauma Nurse Coordinator; Sammie Leonard, Trauma Nurse Coordinator; Dr Stuart Reid; Anna Wilson, Research Nurse; Sarah Bird, Research Nurse
 



Go back
 
Rate this page: